Advertisements


The Remdesivir Study Is Finally Out: Drug Only Helped Those On Oxygen, Finds Mortality Too High For Standalone Treatment

The Remdesivir Study Is Finally Out: Drug Only Helped Those On Oxygen, Finds Mortality Too High For Standalone Treatment.....»»

Category: worldSource: nytMay 22nd, 2020

Experimental drug remdesivir proves effective against COVID-19 in major study, US government officials announce

Gilead Sciences’s remdesivir would be the first treatment to pass such a test against th.....»»

Category: topSource: chicagotribuneApr 29th, 2020

Experimental drug remdesivir proved effective against COVID-19 in major study, drugmaker Gilead says

Gilead Sciences’s remdesivir would be the first treatment to pass such a test against th.....»»

Category: topSource: chicagotribuneApr 29th, 2020

Gilead"s coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug (GILD)

Associated Press A leading coronavirus treatment candidate succeeded in a critical trial, the biotechnology company Gilead .....»»

Category: topSource: businessinsiderApr 29th, 2020

How the cell phone helped reduce drug-related gang deaths

A new study finds a link between cell-phone network build-out and U.S. homicide rates......»»

Category: topSource: marketwatchMay 29th, 2019

Trump-fueled promotion of unproved coronavirus drug generated spike in prescriptions, study finds

JAMA study shows spike on hydroxychloroquine prescriptions as pandemic struck. The spike quickly dropped but overall there were almost a half million extra prescriptions in 10 weeks......»»

Category: topSource: washpost9 hr. 36 min. ago

Trump-fueled push of unproven drugs drove prescriptions, study finds

Publicity about a potential covid-19 treatment created a 200 percent increase in hydroxychloroquine and chloroquine prescriptions in March, researchers said......»»

Category: topSource: washpost17 hr. 6 min. ago

Deciphera Prepares To Collect Revenue After First FDA Approval: "We Are Well-Positioned"

After 17 years of clinical work, Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) finally has a marketable product. The Food and Drug Administration approved Qinlock as a fourth-line treatment of gastrointestinal stromal tumors earlier this month.  read more.....»»

Category: blogSource: benzingaMay 29th, 2020

Roche"s shares rise on news of study testing Actemra, remdesivir in COVID-19 patients

Shares of Roche Holding AG gained 2.4% in premarket trading on Thursday after the drugmaker said it is testing a combination of its rheumatoid arthritis drug Actemra with Gilead Sciences Inc.'s remdesivir in hospitalized COVID-19 patients. Gilead's st.....»»

Category: topSource: marketwatchMay 28th, 2020

Oregon hospitals to receive experimental Covid treatment

The Oregon Health Authority will distribute an experimental Covid-19 treatment to state hospitals. The drug remdesivir has been used to treat patients with severe Covid-19 symptoms, and preliminary testing has shown that patients using it have fa.....»»

Category: topSource: bizjournalsMay 18th, 2020

Raleigh pharma to study coronavirus treatment on patients in U.S.

A Triangle drugmaker that's seen positive results with its Covid-19 treatment internationally can now start treating patients in the U.S. Raleigh's RedHill Biopharma (Nasdaq: RDHL) has received approval from the U.S. Food and Drug Administration .....»»

Category: topSource: bizjournalsMay 10th, 2020

NC drugmaker sees $82 million in federal funding for Covid-19 treatment

A Triangle drug company on the verge of a commercial launch is also bringing in big money to study its potential coronavirus treatment......»»

Category: topSource: bizjournalsMay 10th, 2020

The federal government finally announced initial plans to distribute Gilead"s coronavirus drug remdesivir after days of confusion

AP Photo/Alex Brandon The federal government on Saturday announced initial plans for distributing a promising coronavirus drug, .....»»

Category: topSource: businessinsiderMay 9th, 2020

The same number of people could die from ‘deaths of despair’ as have already died in the U.S. from coronavirus, new study finds

‘More Americans could lose their lives to deaths of despair, deaths due to drug, alcohol, and suicide, if we do not do something immediately.’.....»»

Category: topSource: marketwatchMay 8th, 2020

Infectious-disease doctors ask government to explain how it decides who gets Gilead’s remdesivir

Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug......»»

Category: topSource: marketwatchMay 7th, 2020

Akebia Shares Climb on Positive Anemia Drug Study Results

Company hits 52-week high of $12.25Related Stocks: AKBA, AMGN, FGEN, GSK, OTSKY, MTZPY,.....»»

Category: blogSource: gurufocusMay 7th, 2020

Hospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK"d its emergency use

Associated Press A promising coronavirus treatment called remdesivir was approved last week for emergency use in the US. Now, some hospitals are having a hard time getting the drug for their patients. The US government is deciding which hospitals will .....»»

Category: topSource: businessinsiderMay 6th, 2020

Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient (GILD)

Reuters Gilead Sciences could be.....»»

Category: topSource: businessinsiderMay 3rd, 2020

Coronavirus treatment drug remdesivir to arrive in hospitals this week, Gilead CEO says

The CEO of Gilead Sciences says U.S. hospitals should get enough of its drug to fight COVID-19 to treat as many as 200,0.....»»

Category: topSource: usatodayMay 3rd, 2020

FDA grants Gilead’s remdesivir emergency authorization for COVID-19 treatment

The Food and Drug Administration on Friday granted an emergency use authorization to Gilead Sciences Inc.’s remdesivir, a decade-old experimental therapy first tested on Ebola disease patients, as a COVID-19 treatment......»»

Category: topSource: marketwatchMay 1st, 2020

FDA clears Gilead"s emergency coronavirus treatment remdesivir

The Food and Drug Administration has authorized the emergency use of Gilead’s experimental drug remdesivir for COVID-19 treatment......»»

Category: topSource: foxnewsMay 1st, 2020